Studies on ALS animal models showed that intracerebroventricular or intramuscular administration of a VEGF-expressing lentiviral vector promote angiogenesis, increase blood flow through the spinal cord and exert direct protective effects on neuronal cells, thus reducing disease-specific pathology and extending survival [100,101]. This evidence concerns the gene VEGFA and amyotrophic lateral sclerosis.